Award
National Cancer Institute 5R01CA273123-05
Investigating and modeling MYD88L265P and co-occurring mutations in mature B-cell malignancies
Recipient
National Cancer Institute (NCI), United States
Award Amount
$464,705.00
Ceiling
$464,705.00
Awarded
July 24, 2026
Identifier
5R01CA273123-05
Award for research on MYD88L265P mutation and co-occurring mutations in mature B-cell malignancies, funded by the National Cancer Institute with a total cost of $464,705 for fiscal year 2026.
Description
The project involves studying the molecular mechanisms of MYD88L265P mutation and chromosome 6q deletion in B-cell lymphomas and aims to develop preclinical mouse models for testing therapies.